[Neo-Abiotin for the treatment of gangrenous pulpitis].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D003790:Dental Pulp Necrosis / Q000188:drug therapy*; D006801:Humans; D010636:Phenols / Q000494:pharmacology; D051381:Rats; D012390:Root Canal Therapy
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D010636:Phenols
Neo-Abiotin zur Behandlung der Pulpitis gangraenosa.